Virus News and Research

Latest Virus News and Research

Researchers discover NPC1 protein as crucial for Ebola virus to enter host cells

Although outbreaks are rare, Ebola virus, the cause of Ebola hemorrhagic fever (EHF), is one of the deadliest known viruses affecting humans. According to the World Health Organization (WHO), approximately 1,850 EHF cases with more than 1,200 deaths have been documented since the virus was identified in 1976.

25 Aug 2011

Sarcoma Oncology Center, Aethlon Medical to study ex vivo effectiveness of Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has entered into an agreement with the Sarcoma Oncology Center to study the ex vivo effectiveness of the Aethlon Hemopurifier to remove immunosuppressive exosomes from the blood of advanced-stage cancer patients.

24 Aug 2011

Scientists aim to tackle Hawaii's liver cancer problem with improved detection

Two scientists from the University of Hawaii Cancer Center and The Queen's Medical Center have received a five-year $2.3 million grant from the National Cancer Institute to develop novel methods that can better detect liver cancer through the joint analysis of gene expression and imaging data of the liver.

24 Aug 2011

Repeat HPV testing would reduce unnecessary treatment for women

Doing the human papillomavirus (HPV) test twice with a short interval between tests would reduce the number of women having unnecessary treatment, new research shows.

24 Aug 2011

FDA grants fast track designation for Pharmasset's PSI-938 to treat chronic HCV infection

Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for PSI-938 for the treatment of chronic hepatitis C virus (HCV) infection.

24 Aug 2011

Measles exposure in Philadelphia and Lancaster counties

The Pennsylvania Department of Health and the Philadelphia Department of Public Health are advising the public of exposure to a case of measles in Lancaster and Philadelphia counties.

24 Aug 2011

Study finds children's hospitals underequipped to handle H1N1 pandemics

A new study of children's hospitals nationwide has found them underequipped to handle a major surge of patients in the event of a pandemic, and urges health care institutions and government agencies to immediately review emergency preparedness plans as flu season approaches.

24 Aug 2011

Research may help explain why live attenuated influenza vaccine elicits protection

New research from the Trudeau Institute may help to explain why live attenuated influenza vaccine (LAIV), commonly known as FluMist, elicits protection.

24 Aug 2011

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.

23 Aug 2011

Vertex receives Health Canada approval for INCIVEK to treat hepatitis C

Vertex Pharmaceuticals Incorporated today announced that Health Canada has approved INCIVEK tablets for a broad group of people with genotype 1 chronic hepatitis C with compensated liver disease, including cirrhosis.

23 Aug 2011

Nurse safety measures around highly toxic drugs needed

Nearly 17 percent of nurses who work in outpatient chemotherapy infusion centers reported being exposed on their skin or eyes to the toxic drugs they deliver, according to a new study from the University of Michigan Comprehensive Cancer Center.

22 Aug 2011

Should we be screening blood for hepatisi G?

Hepatitis G virus was identified in 1995. Some little research was carried out on the virus and the US Food and Drug Administration (FDA) declared it a non-harmful virus in 1997. Researchers in Saudi Arabia, writing in the International Journal of Immunological Studies present evidence to suggest that this may have been the wrong decision.

22 Aug 2011

Tiny molecule could bind to B cell EB12 receptor and prevent cancer

Infection with Epstein Barr means that the B cells, which are the primary memory cells of the immune system, are hi-jacked. When the virus has penetrated, researchers observe an excess of a special bio-antenna, a receptor known as EB12, suddenly sprouting from the surface of the B cells. But why they do so remains a mystery.

22 Aug 2011

AHF: Gilead's campaign for FDA approval of Truvada leads to black marketing in Florida

Today AIDS Healthcare Foundation (AHF) decried the fact that the recent campaign by Gilead Sciences Inc. to obtain approval by the U.S. Food & Drug Administration for Truvada as PrEP (pre-exposure prophylaxis) has led to a "black market" for the drug in Florida.

20 Aug 2011

Annual oral rabies vaccination program in eight western Pennsylvania counties

The annual oral rabies vaccination program, which helps control the spread of rabies in wild animals, is underway in eight western Pennsylvania counties.

20 Aug 2011

VOA News examines new drug compound that shows broad-based efficacy in lab tests

VOA News looks at a new drug compound developed by researchers at the Massachusetts Institute of Technology (MIT) that they say has so far "killed every virus it's been tested on in the laboratory." "The drug - known by the acronym DRACO - works by chemically targeting viral-infected cells and prompting them to self-destruct, eliminating the disease in the process," VOA writes.

20 Aug 2011

Emory team identifies conditions that make memory T cells slip away during chronic infections

After recovering from the flu or another acute infection, your immune system is ready to react quickly if you run into the same virus again. White blood cells called memory T cells develop during the infection and help the immune system remember the virus and attack it if it comes back.

19 Aug 2011

Cerus to support ongoing development of INTERCEPT red cell system

Cerus Corporation announced today that it has received a $2.1 million award from the U.S. Department of Defense to support the advanced development of the company's technology for inactivating pathogens and leukocytes in red blood cells.

19 Aug 2011

Isolation of HIV antibodies advances search for AIDS vaccine

A team of researchers has "identified 17 potent antibodies whose discovery opened up valuable pathways in the search for an AIDS vaccine," Agence France-Presse reports.

19 Aug 2011

H1N1 vaccine safe, effective for hemodialysis and kidney transplant patients

When the influenza A (H1N1) virus swept around the world in spring 2009, infection was presumed to be more common in immunosuppressed patients, such as those who have had a kidney transplant. Later that year, the International Societies of Transplantation recommended that transplant recipients receive at least one dose of the H1N1 vaccine, although there was no information on the efficacy of the vaccine in that population.

19 Aug 2011

Virus News and Research

Latest Virus News and Research

Researchers discover NPC1 protein as crucial for Ebola virus to enter host cells

Sarcoma Oncology Center, Aethlon Medical to study ex vivo effectiveness of Hemopurifier

Scientists aim to tackle Hawaii's liver cancer problem with improved detection

Repeat HPV testing would reduce unnecessary treatment for women

FDA grants fast track designation for Pharmasset's PSI-938 to treat chronic HCV infection

Measles exposure in Philadelphia and Lancaster counties

Study finds children's hospitals underequipped to handle H1N1 pandemics

Research may help explain why live attenuated influenza vaccine elicits protection

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

Vertex receives Health Canada approval for INCIVEK to treat hepatitis C

Nurse safety measures around highly toxic drugs needed

Should we be screening blood for hepatisi G?

Tiny molecule could bind to B cell EB12 receptor and prevent cancer

AHF: Gilead's campaign for FDA approval of Truvada leads to black marketing in Florida

Annual oral rabies vaccination program in eight western Pennsylvania counties

VOA News examines new drug compound that shows broad-based efficacy in lab tests

Emory team identifies conditions that make memory T cells slip away during chronic infections

Cerus to support ongoing development of INTERCEPT red cell system

Isolation of HIV antibodies advances search for AIDS vaccine

H1N1 vaccine safe, effective for hemodialysis and kidney transplant patients

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in